- Home
- IDT vs NEO Comparison
IDT vs NEO Comparison
Compare IDT & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDT
- NEO
- Stock Information
- Founded
- IDT 1990
- NEO 2001
- Country
- IDT United States
- NEO United States
- Employees
- IDT N/A
- NEO N/A
- Industry
- IDT Telecommunications Equipment
- NEO Precision Instruments
- Sector
- IDT Telecommunications
- NEO Health Care
- Exchange
- IDT Nasdaq
- NEO Nasdaq
- Market Cap
- IDT 1.3B
- NEO 1.2B
- IPO Year
- IDT 1996
- NEO 1999
- Fundamental
- Price
- IDT $52.21
- NEO $9.42
- Analyst Decision
- IDT
- NEO Strong Buy
- Analyst Count
- IDT 0
- NEO 10
- Target Price
- IDT N/A
- NEO $19.78
- AVG Volume (30 Days)
- IDT 149.8K
- NEO 1.5M
- Earning Date
- IDT 03-06-2025
- NEO 04-29-2025
- Dividend Yield
- IDT 0.46%
- NEO N/A
- EPS Growth
- IDT 117.30
- NEO N/A
- EPS
- IDT 3.15
- NEO N/A
- Revenue
- IDT $1,221,391,000.00
- NEO $660,566,000.00
- Revenue This Year
- IDT N/A
- NEO $12.89
- Revenue Next Year
- IDT N/A
- NEO $11.36
- P/E Ratio
- IDT $16.71
- NEO N/A
- Revenue Growth
- IDT 1.75
- NEO 11.65
- 52 Week Low
- IDT $33.84
- NEO $8.98
- 52 Week High
- IDT $58.77
- NEO $19.11
- Technical
- Relative Strength Index (RSI)
- IDT 59.32
- NEO 39.88
- Support Level
- IDT $50.55
- NEO $9.00
- Resistance Level
- IDT $53.00
- NEO $10.37
- Average True Range (ATR)
- IDT 1.58
- NEO 0.51
- MACD
- IDT 0.17
- NEO 0.10
- Stochastic Oscillator
- IDT 82.71
- NEO 30.66
About IDT IDT Corporation Class B
IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.